Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: post observation period 7 days, no data on strain.

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1967
Report date:
1967

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 401 (Acute Oral Toxicity)
Deviations:
yes
Remarks:
post observation period 7 days, no data on strain.
GLP compliance:
no
Test type:
standard acute method
Limit test:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
N,N''-(isobutylidene)diurea
EC Number:
228-055-8
EC Name:
N,N''-(isobutylidene)diurea
Cas Number:
6104-30-9
Molecular formula:
C6H14N4O2
IUPAC Name:
N,N''-(2-methylpropane-1,1-diyl)diurea
Details on test material:
purity ca. 90-96% (0-3% urea, 2% potassium sulfate)

Test animals

Species:
rat
Strain:
not specified
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Weight at study initiation: 126-218 g

no further data

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
water
Details on oral exposure:
The doses were applied as 10%, 16% or 30% preparations of the test substance in water
Doses:
800, 1000, 1600, 3200, 6400, 10000 mg/kg bw
No. of animals per sex per dose:
5
Control animals:
no
Details on study design:
- Duration of observation period following administration: 7 days
- Frequency of observations and weighing: Group-wise documentation of clinical signs was performed over the 7 day study period.
Body weight was determined before the start of the study only, as it was needed for determination of dose.
- Necropsy of survivors performed: yes
- Other examinations performed: The clinical signs and findings were reported in summary form .
Statistics:
On the basis of the observed lethality, the LD50 value was estimated or determined using a graphical evaluation of the dose response curve on probability paper .

Results and discussion

Effect levels
Key result
Sex:
male/female
Dose descriptor:
LD50
Effect level:
> 10 000 mg/kg bw
Mortality:
no deaths
Clinical signs:
other: 800-1600 mg/kg bw: no symptoms 3200-10000 mg/kg bw: piloerection and tachypnoea
Gross pathology:
Four animals showed chronic bronchitis and bronchi ectases, all other animals without findings in the organs . Necropsy was
performed by a pathologist .

Any other information on results incl. tables

Results are given as dead animals/total number of animals at this dose

at 24 h, 48 h and 7 days after dosing:  

800 mg/kg bw: 0/10, 0/10, 0/10  

1000 mg/kg bw: 0/10, 0/10, 0/10  

1600 mg/kg bw: 0/10, 0/10, 0/10  

3200 mg/kg bw: 0/10, 0/10, 0/10  

6400 mg/kg bw: 0/10, 0/10, 0/10  

10000 mg/kg bw: 0/10, 0/10, 0/10

Applicant's summary and conclusion